06990.HK
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 489.40
−1.49%Margins
Gross margin
71.9%
EBITDA margin
-17.7%
EBIT margin
-16.4%
Net margin
-18.6%
FCF margin
-14.6%
-8.6%
Return on equity
-7.0%
Return on assets
-7.4%
Return on invested capital
0.36x
Asset turnover
-HKD 223.5M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025